Johannesburg – Pharmaceutical company Cipla Medpro SA said on Tuesday it expected its earnings per share and headline earnings per share in the six months to June 2012 to between 32% and 38% lower compared with the same period a year ago.
The comparative period last year included the pre-tax settlement income of R68.8m and unrealised gains on the forward exchange contracts of R28.6m (2012: unrealised loss of R34.2m).